ClinicalTrials.gg
Sign In

Supranuclear Palsy, Progressive clinical trials

The registry lists 171 studies for Supranuclear Palsy, Progressive across more than 10 countries. 51 are recruiting or about to start. 88 of them are mainly about Supranuclear Palsy, Progressive (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Supranuclear Palsy, Progressive studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
81
Recruiting
38
Status unknown
17
Active, not recruiting
11
Terminated
9
Not yet recruiting
8

Phase

Phase 2
31
Phase 1
23
Phase 3
9
Early Phase 1
8
Phase 4
2

Where

United States
84
France
22
Italy
22
Germany
21
United Kingdom
17
Canada
15

Who runs them

University of California, San Francisco (8) · University of Pennsylvania (5) · Adam Boxer (4) · Massachusetts General Hospital (4) · Molecular NeuroImaging (4) · IRCCS San Raffaele Roma (4) · Assistance Publique Hopitaux De Marseille (3) · Nantes University Hospital (3)

What is being tested here

Drugs under test in Supranuclear Palsy, Progressive studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
AADvac1202
Flortaucipir103
NIO752101
Tributyrin101
Nicotinamide-beta-riboside101
Coenzyme Q10013
Tilavonemab003
Gosuranemab003
Bepranemab002
PI-2620002

Drug classes tested here Cholinesterase inhibitors 3

Coming up

1phase 3 study under way
18studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 38 Supranuclear Palsy, Progressive studies recruiting now, 22 (58%) set no upper age limit and 2 (5%) stop at 75 or younger. 5 (13%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 14 (37%) take healthy volunteers.

Recruiting studies that take each age, of 38
AgeWomenMen
104 (11%)4 (11%)
1822 (58%)22 (58%)
3028 (74%)28 (74%)
4032 (84%)32 (84%)
5038 (100%)38 (100%)
6538 (100%)38 (100%)
7538 (100%)38 (100%)
8531 (82%)31 (82%)

Across all 171 studies, recruiting or not: 4% stop at 75 or younger and 1% at 65; 8% take children; 0% are for women only and 0% for men only; 37% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Supranuclear Palsy, Progressive studies take

Of 15 phase 1 interventional studies under Supranuclear Palsy, Progressive, half reached primary completion within 22 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 122 mo17–23 · 15 studies——
Interventional, no phase45 mo29–… · 28 studies——
Observational81 mo54–… · 37 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 171. Browse all 171 → or search them.